Literature DB >> 24510587

Potentially functional polymorphisms in aminoacyl-tRNA synthetases genes are associated with breast cancer risk in a Chinese population.

Yisha He1, Jianhang Gong1, Yanru Wang2, Zhenzhen Qin1,3, Yue Jiang1,3, Hongxia Ma1,3, Guangfu Jin1,3, Jiaping Chen1, Zhibin Hu1,3, Xiaoxiang Guan2, Hongbing Shen1,3.   

Abstract

Aminoacyl-tRNA synthetases (ARSs) are responsible for cellular protein synthesis and cell viability involving in various process of tumorigenesis. We hypothesized that genetic variants in core ARSs genes may play an important role in the development of breast cancer. Thus, we conducted a case-control study including 1064 breast cancer cases and 1073 cancer-free controls to evaluate the associations of 28 potentially functional polymorphisms in 12 core ARSs genes (AARS, CARS, EPRS, HARS, KARS, LARS, MARS, QARS, RARS, VARS, WARS, and YARS) with breast cancer risk. We found significant associations with the risk of breast cancer for rs34087264 in AARS [odds ratio (OR) = 1.15, 95% confidence interval (CI) = 1.01-1.31], rs801186 in HARS (OR = 1.29, 95% CI = 1.08-1.54), rs193466 in RARS (OR = 1.17, 95% CI = 1.02-1.35), and rs2273802 in WARS (OR = 1.14, 95% CI = 1.01-1.30). We further observed significant interactions between rs2273802 and age at the first live birth (P = 0.041), and between rs801186 and age on breast cancer risk (P = 0.018). Combined analysis of these four SNPs showed a significant allele-dosage association between the number of risk alleles and breast cancer risk (Ptrend  = 2.00 × 10(-4) ). Compared with individuals with "0-2" risk alleles, those carrying "3," "4," or "5 or more" risk alleles had a 1.32 (95% CI = 1.07-1.64), 1.48 (95% CI = 1.45-1.91), or 1.60 folds (95% CI = 1.06-2.41) risk of breast cancer, respectively. These findings indicate that genetic variants in core ARSs genes may modify the individual susceptibility to breast cancer in Chinese population.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  aminoacyl-tRNA synthetases; association study; breast cancer; polymorphism; susceptibility

Mesh:

Substances:

Year:  2014        PMID: 24510587     DOI: 10.1002/mc.22128

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

1.  Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.

Authors:  Yingmei Yang; Zhaoyun Li; Qianyi Zhong; Lei Zhao; Yichao Wang; Hongbo Chi
Journal:  Gland Surg       Date:  2022-05

Review 2.  Functional and pathologic association of aminoacyl-tRNA synthetases with cancer.

Authors:  Yulseung Sung; Ina Yoon; Jung Min Han; Sunghoon Kim
Journal:  Exp Mol Med       Date:  2022-05-02       Impact factor: 12.153

Review 3.  Roles of aminoacyl-tRNA synthetase-interacting multi-functional proteins in physiology and cancer.

Authors:  Zheng Zhou; Bao Sun; Shiqiong Huang; Dongsheng Yu; Xiaochuan Zhang
Journal:  Cell Death Dis       Date:  2020-07-24       Impact factor: 8.469

4.  YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling.

Authors:  Cheng Zhang; Xiaoting Lin; Qian Zhao; Yakun Wang; Fangli Jiang; Congcong Ji; Yanyan Li; Jing Gao; Jian Li; Lin Shen
Journal:  J Cancer Res Clin Oncol       Date:  2020-01-08       Impact factor: 4.553

Review 5.  Roles of Aminoacyl-tRNA Synthetases in Cancer.

Authors:  Zheng Zhou; Bao Sun; Anzheng Nie; Dongsheng Yu; Meng Bian
Journal:  Front Cell Dev Biol       Date:  2020-11-27

6.  Identification of natural compounds tubercidin and lycorine HCl against small-cell lung cancer and BCAT1 as a therapeutic target.

Authors:  Jungang Chen; Lindsey Barrett; Zhen Lin; Samantha Kendrick; Shengyu Mu; Lu Dai; Zhiqiang Qin
Journal:  J Cell Mol Med       Date:  2022-03-22       Impact factor: 5.295

7.  The plasma peptides of breast versus ovarian cancer.

Authors:  Jaimie Dufresne; Pete Bowden; Thanusi Thavarajah; Angelique Florentinus-Mefailoski; Zhuo Zhen Chen; Monika Tucholska; Tenzin Norzin; Margaret Truc Ho; Morla Phan; Nargiz Mohamed; Amir Ravandi; Eric Stanton; Arthur S Slutsky; Claudia C Dos Santos; Alexander Romaschin; John C Marshall; Christina Addison; Shawn Malone; Daren Heyland; Philip Scheltens; Joep Killestein; Charlotte Teunissen; Eleftherios P Diamandis; K W M Siu; John G Marshall
Journal:  Clin Proteomics       Date:  2019-12-23       Impact factor: 3.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.